Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$20.54 - $24.67 $2.65 Million - $3.18 Million
128,825 New
128,825 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$14.71 - $24.18 $310,219 - $509,932
21,089 Added 26.27%
101,382 $2.24 Million
Q2 2022

Aug 15, 2022

BUY
$12.93 - $20.29 $34,148 - $53,585
2,641 Added 3.4%
80,293 $1.15 Million
Q1 2022

May 11, 2022

BUY
$16.73 - $21.58 $69,529 - $89,686
4,156 Added 5.65%
77,652 $1.47 Million
Q4 2021

Feb 11, 2022

BUY
$15.48 - $26.52 $641,011 - $1.1 Million
41,409 Added 129.05%
73,496 $1.37 Million
Q3 2021

Nov 12, 2021

BUY
$24.15 - $30.5 $150,261 - $189,771
6,222 Added 24.06%
32,087 $863,000
Q2 2021

Aug 11, 2021

BUY
$25.53 - $36.11 $660,333 - $933,985
25,865 New
25,865 $808,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $423M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.